We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

GE Inks $21 Billion Biopharma Sale to Danaher, a U-turn Decision

News   Feb 27, 2019 | Original story from genomeweb

 
GE Inks $21 Billion Biopharma Sale to Danaher, a U-turn Decision

Image credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Native American Ancestry Associated With Increased EGFR Mutations

News

Using a new method, Scientists have analyzed tumour samples of Latin American patients suffering from lung cancer, to establish which populations would benefit from further screening.

READ MORE

Sensor Can Detect Scarred or Fatty Liver Tissue

News

A new method for diagnosing fatty liver disease has been established, using NMR, that can detect both the disease and fibrosis.

READ MORE

CRISPR Tagging Improves Accuracy Of Model Cells Grown From Stem Cells

News

Researchers have found a way to program stem cells to differentiate into a particular cell type, using gene regulatory networks.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE